Brief: Anavex Life Sciences Announces Issuance Of New U.S. Patent Expanding Anavex®2-73 Blarcamesine Intellectual Property Portfolio For Treatment Of Hypertension
01/05/2023 12:41
May 1 (Reuters) - Anavex Life Sciences Corp AVXL.O :
* ANAVEX LIFE SCIENCES ANNOUNCES ISSUANCE OF NEW U.S. PATENT
EXPANDING ANAVEX®2-73 (BLARCAMESINE) INTELLECTUAL PROPERTY
PORTFOLIO FOR THE TREATMENT OF HYPERTENSION
Source text for Eikon: ID:nGNX4DZ06m
Further company coverage: AVXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board